Pancreatic Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
K
Active, not recruiting
  • Pancreatic Cancer
  • Talimogene laherparepvec
  • New York, New York
    Columbia University Medical Center
2022-03-31
Mar 31, 2022
N
Recruiting
  • Gastrointestinal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Pancreatic Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
K
Recruiting
  • Pancreatic Cancer
  • Biliary Tract Cancer
  • Physical exercise
  • Oslo, Norway
  • +1 more
2022-03-30
Mar 30, 2022
P
Recruiting
  • Oncology
  • +9 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +2 more
2022-04-07
Apr 7, 2022
N
Active, not recruiting
  • Colon Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Pancreatic Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Completed
  • Gastrointestinal Cancer
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    N
    Recruiting
    • Advanced Solid Tumor
    • +26 more
    • Huntersville, North Carolina
      Carolina BioOncology Institute
    2022-04-06
    Apr 6, 2022
    K
    Recruiting
    • Pancreatic Cancer
    • Advanced Cancer
    • Boston, Massachusetts
    • +2 more
    2022-04-06
    Apr 6, 2022
    B
    Completed
    • Colorectal Cancer
    • +7 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    2022-03-30
    Mar 30, 2022
    N
    Recruiting
    • Pancreatic Cancer
    • +15 more
    • Grand Rapids, Michigan
    • +2 more
    2022-04-05
    Apr 5, 2022
    M
    Recruiting
    • Patient Reported Outcome Measures
    • +7 more
    • Observational Cohort
    • Boston, Massachusetts
      Massachusetts General Hospital
    2022-04-04
    Apr 4, 2022
    S
    Completed
    • Acute Myeloid Leukemia
    • +8 more
    • DSP-7888 Dosing Emulsion
    • Denver, Colorado
    • +7 more
    2022-04-04
    Apr 4, 2022
    L
    Available
    • Non Small Cell Lung Cancer
    • +6 more
    • Goodyear, Arizona
    • +68 more
    2022-04-05
    Apr 5, 2022
    H
    Recruiting
    • Non Small Cell Lung Cancer
    • +6 more
    • Encinitas, California
    • +5 more
    2022-04-04
    Apr 4, 2022
    R
    Recruiting
    • Pancreatic Cancer
      • Shanghai, China
        Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
      2022-03-29
      Mar 29, 2022
      A
      Recruiting
      • Pancreatic Cancer
      • +7 more
      • Glasgow, United Kingdom
      • +5 more
      2022-04-05
      Apr 5, 2022
      I
      Recruiting
      • Pancreatic Cancer
      • Echoendoscopy
      • Strasbourg, France
        Service de Chirurgie Digestive et Endocrinienne
      2022-03-28
      Mar 28, 2022
      N
      Not yet recruiting
      • Pancreatic Cancer
      • +15 more
      • (no location specified)
      2022-03-27
      Mar 27, 2022
      P
      Recruiting
      • Breast Cancer
      • +8 more
      • Denver, Colorado
      • +1 more
      2022-04-01
      Apr 1, 2022
      A
      Recruiting
      • Gynecologic Cancer
      • +11 more
      • Neoantigen specific TCR-T cell drug product
      • Aldesleukin (IL-2)
      • Houston, Texas
        MD Anderson Cancer Center
      2022-04-01
      Apr 1, 2022